Trademark Overview
On Friday, January 30, 2004, a trademark application was filed for CANCERGENIE with the United States Patent and Trademark Office. The USPTO has given the CANCERGENIE trademark a serial number of 78359972. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, April 17, 2005. This trademark is owned by ChondroGene Limited. The CANCERGENIE trademark is filed in the Medical Instrument Products category with the following description:
computer software, optical disc media, and other electronic media providing gene expression profile information for use in predicting cancer, selecting therapeutics, evaluating efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluating treatment of cancer; point-of-care equipment for carrying out and/or evaluation of medical-diagnostic examinations related to cancer; diagnostic devices for clinical, laboratory, or medical use to diagnose, prognose, predict or evaluate cancer ; computer software, optical disc media, and other electronic media providing gene expression profile information for use in predicting cancer, selecting therapeutics, evaluating efficacy and toxicity of treatments, and evaluating treatment programs; diagnostic devices for selecting therapeutics, evaluating efficacy and toxicity of a therapeutic treatment regime, and evaluat...
